Novartis Venture Fund

Novartis Venture Fund invests in early-stage novel therapeutics, platforms, and medtech. Focuses on unmet needs, clinical impact, proprietary science, strong teams, and capital efficiency. Global reach.

Funding Stage: Pre-Seed / Seed, Series A/B, Series C & Beyond

Investor type: Corporate VC

Investment Areas: Finance, Therapeutics, Venture Capital, Investing, Life Science

Country: Switzerland